Chrysalis Biotherapeutics, Inc.
Pharmaceutical company · Galveston, Texas, United States
Chrysalis Biotherapeutics, Inc. is a pharmaceutical company headquartered in Galveston, Texas, United States. It has received 6 US government small-business research awards (SBIR/STTR) from health agencies, $8.1 million in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $515,000 sold in a notice filed in 2024.
Chrysalis Biotherapeutics at a glance
What does Chrysalis Biotherapeutics do?
US government research funding
6 SBIR/STTR small-business research awards from US health agencies, $8.1 million in total (2010 to 2016). NIH funding came from the National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $515,000 sold (2024).
Frequently asked questions about Chrysalis Biotherapeutics
Where is Chrysalis Biotherapeutics headquartered?
Chrysalis Biotherapeutics, Inc. is headquartered in Galveston, Texas, United States.
What does Chrysalis Biotherapeutics do?
Chrysalis Biotherapeutics, Inc. is a pharmaceutical company.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences